Dr. Praful Ravi is a Medical Oncologist, Medical Director of GU Theranostics and Associate Director for Clinical Research at the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, and an Assistant Professor of Medicine at Harvard Medical SChool. He received his medical degree from the University of Cambridge and obtained Membership of the Royal College of Physicians (MRCP) before completing a residency in Internal Medicine at Mayo Clinic. He subsequently completed a fellowship in Medical Oncology at Dana-Farber Cancer Institute. He undertakes clinical trials and translational research in prostate cancer, specifically focusing on (1) radiopharmaceutical therapy and theranostics, (3) endpoints and outcomes in localized prostate cancer, and (3) neoadjuvant therapy in high-risk prostate cancer. He is interested in developing novel treatments and identifying biomarkers that may enable tailoring of cancer therapy to each patient.
Disclosures:
- Employment: none
- Compensation: Bayer: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Grant Research Funding-End Date: -- ;Curium: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Grant Research Funding-End Date: -- ;Janssen: Consultant, Grant Research Funding-End Date: -- ;AstraZeneca: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: -- ;Blue Earth Diagnostics: Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date
- Ownership: none
- Leadership: none